Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours
about
Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signalingTargeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent mannerA Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells.Wnt signaling as a possible promoting factor of cell differentiation in pleomorphic adenomasThe CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.Oral epithelial stem cells - implications in normal development and cancer metastasis.Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.Can we safely target the WNT pathway?A bioluminescence reporter mouse that monitors expression of constitutively active β-cateninThe evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapiesCardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo.Cracking the survival code: autophagy-related histone modifications.Safely targeting cancer stem cells via selective catenin coactivator antagonism.Elevated expression of histone demethylase PHF8 associates with adverse prognosis in patients of laryngeal and hypopharyngeal squamous cell carcinoma.miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.The role of HOX genes in head and neck squamous cell carcinoma.Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.Genetic alterations in salivary gland cancers.Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation.WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited.Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis.Crosstalk between SOXB1 proteins and WNT/β-catenin signaling in NT2/D1 cells.CBP/Catenin antagonists: Targeting LSCs' Achilles heel.ICG-001 suppresses growth of gastric cancer cells and reduces chemoresistance of cancer stem cell-like population.Break the loop, escape the cycle?C3G shows regulated nucleocytoplasmic exchange and represses histone modifications associated with euchromatinDifferentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer
P2860
Q26861795-B58B600A-4D14-4038-9435-115501B07028Q26991723-840E5D44-31FB-4751-A008-624C55B47DE8Q28543151-7FBE5D8F-51FA-4F70-B527-A165ACF9736BQ30401808-039F5186-5E2C-4C29-9810-23C7C10AB60AQ33926141-9D4AF416-D5B4-431F-8452-0C91873B0FE7Q33962420-7A99AFEA-9971-40D8-9F8F-6385503A44E7Q34041619-E00A97F6-54DA-4832-85F9-3C67B722E90DQ34147649-C7F359BD-5A6D-4E73-9DF3-8C1878231504Q35505126-564A8927-7DD2-4861-B405-4AA2155AAAB8Q35591995-2779AD82-BFA7-46F6-ACC5-725AEAEA45A8Q36295368-DBD52A7F-FC18-41D2-9CDF-13F39FC8F66CQ36515479-4589E0FD-1C4B-4594-A1E3-B06538BFE610Q36729529-D3663DB2-1443-43A4-94C0-73247BC6B12DQ38178832-B2BBB52E-E61D-4B2F-B770-00B55A071C12Q38224211-4DB5D6EE-B047-4D9A-8136-003A7872CB9CQ38388826-D45B8102-194A-4973-AAAC-35C793F3CF0FQ38411340-BB438463-3867-4EEB-BA93-E3A47F50641EQ38569786-C60C26EC-539D-4718-90D3-1986DE377B5CQ38667649-86CC9835-81EF-4F95-A6DA-086860740015Q38734645-9E665F82-5BD7-4ADB-A9BF-3312181B04C3Q38755879-1BA88C08-71EC-4334-957E-2E84575B37ADQ38786359-62DC18AB-019F-4611-AAF7-002BB75024E9Q38908764-32DCB3FC-EFCF-450A-81FF-4185075A9EE1Q38926368-F0F03308-0483-4EA7-AE1F-5F8FA84229FFQ38977947-3749A624-373F-4175-8D94-4C1AFA5FF37DQ39289235-35E02380-0446-4CDB-8006-A929D588E1EDQ41273119-5474AB99-2975-40F5-9B06-E4A017600358Q41871516-CB511574-0D5B-4CF0-9A87-19C184B23F51Q42292410-069EF649-08EA-4892-906F-F3FA2B555F0EQ52622302-ED89E80B-8BAA-4D54-A808-ACAC2A28CFCAQ55383144-ED12A85A-CDCB-4066-96A1-33CB794B16E2Q58197289-70EE8086-7869-4D51-B7B8-A70FC7D71F1D
P2860
Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Wnt/β-catenin signalling induc ...... nges in salivary gland tumours
@en
Wnt/β-catenin signalling induc ...... ges in salivary gland tumours.
@nl
type
label
Wnt/β-catenin signalling induc ...... nges in salivary gland tumours
@en
Wnt/β-catenin signalling induc ...... ges in salivary gland tumours.
@nl
prefLabel
Wnt/β-catenin signalling induc ...... nges in salivary gland tumours
@en
Wnt/β-catenin signalling induc ...... ges in salivary gland tumours.
@nl
P2093
P2860
P356
P1433
P1476
Wnt/β-catenin signalling induc ...... nges in salivary gland tumours
@en
P2093
Frauke Kosel
Jane D Holland
Jörg H Schipper
Klaus Eckert
Liang Fang
Michael Kahn
Peter Wend
Qionghua Zhu
Simone Hindersin
Stephan Lehr
P2860
P304
P356
10.1038/EMBOJ.2013.127
P407
P577
2013-06-04T00:00:00Z